A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris.
Phase of Trial: Phase II
Latest Information Update: 29 Apr 2017
At a glance
- Drugs E 6201 (Primary) ; Calcipotriol
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 22 Jun 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2009-014815-11).
- 05 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jan 2011 New trial record